Actively Recruiting

Phase Not Applicable
Age: 30Years +
All Genders
NCT07432126

Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal

Led by Kathmandu University School of Medical Sciences · Updated on 2026-03-10

398

Participants Needed

1

Research Sites

98 weeks

Total Duration

On this page

Sponsors

K

Kathmandu University School of Medical Sciences

Lead Sponsor

I

Institute for Implementation Science and Health

Collaborating Sponsor

AI-Summary

What this Trial Is About

Hypertension (HTN) and diabetes mellitus are significant global public health challenges, contributing to 13.5% of premature deaths, 54% of incident strokes, and 47% of coronary heart disease cases (HTN), and increasing risks of cardiovascular diseases, kidney failure, and other complications (diabetes). In Nepal, HTN prevalence is 24.5% and diabetes affects 5.8% of adults (2019 Nepal STEPS Survey), with many cases undiagnosed or poorly managed, and an estimated 60% co-morbidity among diabetic individuals. Nepal's Package of Essential Non-Communicable Diseases (PEN), implemented since 2017, targets both conditions, but multi-level barriers limit its facility-based effectiveness. This study addresses the need for cost-effective, evidence-based strategies for HTN and diabetes management in low-resource settings, focusing on marginalized populations. It proposes a Type II hybrid implementation-effectiveness study with two objectives: (1) evaluate implementation outcomes (reach, adoption, implementation, maintenance) of the Female Community Health Volunteers (FCHVs)-led integrated HTN and diabetes management using the RE-AIM framework; (2) assess effectiveness compared to facility-based PEN on systolic blood pressure and fasting blood sugar at 12 months. FCHVs will deliver integrated health education, form peer groups, and coordinate care. Using a mixed-method approach, the study involves a cluster randomized controlled trial with participants, collecting quantitative data on implementation, supplemented by in-depth interviews (8-16 patients) and focus group discussions (2 FGDs with FCHVs), with qualitative tracking logs. The intervention adapts a prior FCHV-led HTN trial to integrate diabetes management. FCHVs will receive 3-day training on screening, counseling, BP and blood sugar monitoring, and referrals for both conditions. Mass screening will identify HTN and diabetes cases, forming monthly FCHV groups for lifestyle counseling, BP, and glucose tracking, with family involvement. Monthly referrals will link uncontrolled cases to facilities. This aims to enhance integrated HTN and diabetes management, fostering community engagement and healthcare coordination, with findings to inform scalable NCD strategies in Nepal.

CONDITIONS

Official Title

Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal

Who Can Participate

Age: 30Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 30 years or older
  • Have high blood pressure of 140/90 mmHg or are taking hypertension medication
  • Have high blood sugar of 6.5% or more (HbA1c) or are taking diabetes medication
  • Are able to provide informed consent
Not Eligible

You will not qualify if you...

  • Have any form of disabilities limiting participation in the study
  • Have severe illness requiring bed rest
  • Are pregnant women due to their special health needs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institute for Implementation Science and Health

Kavre, Bagmati, Nepal

Actively Recruiting

Loading map...

Research Team

A

Archana Shrestha, PhD

CONTACT

B

Bihungum Bista, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here